Miguel Xavier
Fernandes
Researcher in the period 2013-2022
University of Turin
Turín, ItaliaPublications in collaboration with researchers from University of Turin (1)
2022
-
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
Frontiers in Pharmacology, Vol. 13